Back to search

Article

Gut delivery of pentameric GLP-1 using genetically engineered <i>Bacillus subtilis</i>

2025-10-07

Abstract excerpt

Glucagon-like peptide-1 (GLP-1) receptor agonists and GLP-1 analogs are widely used for type 2 diabetes and weight management, but current approaches can be limited by manufacturing complexity, cost, formulation requirements, and the need for repeated administration. Living microbial delivery systems offer a potential strategy for sustained gastrointestinal production of therapeutic peptides, yet achieving stable...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
61223ad7-7776-5931-9411-99595ea25ae7
DOI
10.1101/2025.10.07.680898
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gut delivery of pentameric GLP-1 using genetically engineered <i>Bacillus subtilis</i>DOI 10.1101/2025.10.07.680898
Select a neighboring publication to make it the new centre.